A verified 5-Amino-1MQ test report provides critical quantitative data on compound identity, purity, and safety metrics for laboratory experimentation. PX1 Research delivers lot-specific Certificate of Analysis (COA) documentation generated via high-performance analytical testing to support preclinical investigations into NNMT inhibition and bioenergetics.
A verified 5-Amino-1MQ test report provides critical quantitative data on compound identity, purity, and safety metrics for laboratory experimentation. PX1 Research delivers lot-specific Certificate of Analysis (COA) documentation generated via high-performance analytical testing to support preclinical investigations into NNMT inhibition and bioenergetics.
A comprehensive 5-Amino-1MQ test report verifies chemical identity, purity percentage, and safety parameters through quantitative analytical methods including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), Mass Spectrometry (MS), and Bacterial Endotoxin Testing (LAL assay). This documentation confirms batch consistency for laboratory investigations into nicotinamide N-methyltransferase (NNMT) inhibition and cellular energy modulation.
In analytical chemistry, every batch of 5-Amino-1MQ must meet rigorous purity criteria (typically ≥98.0% by RP-HPLC peak area) and mass confirmation (ESI-MS) to guarantee that experimental observations stem directly from the active molecule rather than synthesis byproducts. When ordering from our complete catalog of research peptides and small molecules, researchers receive lot-traced documentation reflecting independent laboratory testing.
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a selective, membrane-permeable small-molecule quinolinium derivative engineered specifically as an inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). Unlike larger amino acid chains, 5-Amino-1MQ possesses a compact aromatic framework with a molecular formula of C10H11N2+ and a monoisotopic mass of approximately 159.09 Da (calculated as the free cation).
Because of its small molecular footprint and positive charge, 5-Amino-1MQ readily crosses cellular membranes in cultured cell lines and organoid models. Interpreting a chemical test report requires confirming both the precise molecular weight via Electrospray Ionization Mass Spectrometry (ESI-MS) and the salt form (typically iodide or chloride), which directly impacts stoichiometry and concentration calculations in laboratory assays.
The primary mechanism of action reported for 5-Amino-1MQ in preclinical literature is the direct inhibition of cytosolic nicotinamide N-methyltransferase (NNMT). NNMT is a key metabolic enzyme predominantly expressed in adipose tissue, liver, and skeletal muscle that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH).
When NNMT activity is elevated, the methyl donor SAM and the NAD+ precursor nicotinamide are rapidly consumed, reducing the availability of substrates necessary for cellular energy production. Preclinical studies suggest that by selectively blocking NNMT catalytic activity, 5-Amino-1MQ prevents the irreversible methyl-tagging and excretion of nicotinamide, effectively preserving NAM for recycling within the NAD+ salvage pathway.
By salvaging intracellular nicotinamide, 5-Amino-1MQ indirectly increases intracellular nicotinamide adenine dinucleotide (NAD+) pools without requiring exogenous NAD+ administration. Elevated intracellular NAD+ concentrations activate key downstream NAD+-dependent enzymes, including sirtuin-1 (SIRT1) and poly(ADP-ribose) polymerases (PARPs), which govern mitochondrial biogenesis, oxidative phosphorylation, and DNA repair mechanisms.
In vitro data indicate that incubating metabolic cell lines with 5-Amino-1MQ leads to increased basal respiration, elevated oxygen consumption rates (OCR), and enhanced adenosine triphosphate (ATP) synthesis. Researchers utilizing our central research library hub can examine documented studies illustrating how NNMT inhibition restores youthful bioenergetic profiles in senescent or high-fat cell models.
In animal models evaluating metabolic regulation, 5-Amino-1MQ has been extensively studied for supporting fat-metabolism research. In rodent models of diet-induced obesity, systemic administration of 5-Amino-1MQ resulted in marked reductions in adipocyte hypertrophy, decreased white adipose tissue mass, and elevated resting energy expenditure without alterations in cumulative food intake.
Gene expression profiling of adipose tissue from treated preclinical models demonstrated an up-regulation of biomarkers associated with fatty acid beta-oxidation and mitochondrial uncoupling proteins (e.g., UCP1). These findings indicate that 5-Amino-1MQ serves as an effective laboratory tool for exploring interventions targeting metabolic dysfunction, lipid accumulation, and energy partition dynamics.
A valid 5-Amino-1MQ test report relies on three core analytical pillars to verify compound integrity prior to in vitro or in vivo administration:
1. Reverse-Phase HPLC (RP-HPLC): Determines chromatographic purity by calculating the ratio of the target compound peak area relative to total integrated peak area. A high-quality report must show ≥98.0% purity. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies structural identity by confirming the single parent ion mass charge ratio (m/z) matching 5-Amino-1MQ. 3. Bacterial Endotoxin Assay (LAL): Quantifies pyrogen levels to confirm values remain below strict threshold limits (<0.05 EU/mg) for cellular toxicity safety.
When structuring comparative metabolic experiments, researchers often evaluate 5-Amino-1MQ alongside other agents targeting mitochondrial output and cellular expenditure. For instance, while 5-Amino-1MQ functions through cytosolic NNMT inhibition to elevate NAD+ levels, mitochondrial-derived peptides like MOTS-c directly regulate nuclear gene expression related to metabolic homeostasis and glucose clearance.
Similarly, synthetic nuclear receptor agonists such as SLU-PP-332 act as estrogen-related receptor (ERR) stimulators to enhance oxidative muscle fiber density, whereas direct pathway intermediates detailed in our NAD+ research bypass enzymatic blockade entirely. Comparing these distinct pathways allows laboratory investigators to dissect specific mechanisms of bioenergetic regulation.
To preserve chemical stability and prevent degradation, lyophilized 5-Amino-1MQ powder should be stored desiccated at -20°C or -80°C, protected from light and ambient air. 5-Amino-1MQ demonstrates robust solubility in polar organic solvents such as dimethyl sulfoxide (DMSO) and ethanol, and moderate solubility in standard aqueous buffer systems (PBS, pH 7.4).
Reconstitution should take place within a sterile laminar flow hood using high-grade solvents. Concentrated stock solutions prepared in DMSO can be aliquoted into single-use microcentrifuge tubes and stored at -80°C to eliminate damage caused by repeated freeze-thaw cycles. Prior to assay addition, researchers should verify complete solubilization via spectrophotometric optical density checks.
PX1 Research manufactures all research compounds within USA-based, state-of-the-art facilities operating under strict GMP-compliant quality standards. Every batch of 5-Amino-1MQ undergoes rigorous testing across independent, ISO 17025 accredited laboratories to guarantee total lot traceability, analytical precision, and chemical purity.
By maintaining strict control over synthesis parameters and providing comprehensive, lot-specific test reports with every order, PX1 Research provides academic and corporate research institutions with reliable reference standards. Laboratory teams can reference complete analytical profiles to ensure data reproducibility across all experimental setups.
What core analytical metrics are included in a 5-Amino-1MQ test report?
A standard 5-Amino-1MQ test report includes RP-HPLC chromatograms verifying overall purity (≥98.0%), ESI-MS spectra confirming molecular mass, and LAL assay results demonstrating endotoxin control below strict threshold limits (<0.05 EU/mg).
What is the primary target of 5-Amino-1MQ in research models?
5-Amino-1MQ functions as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme involved in methyl-group transfer and nicotinamide clearance.
How does 5-Amino-1MQ contribute to intracellular NAD+ elevation?
By inhibiting NNMT, 5-Amino-1MQ prevents the irreversible conversion of nicotinamide into 1-methylnicotinamide, preserving nicotinamide for recycling through the salvage pathway into NAD+.
Is 5-Amino-1MQ a peptide or a small molecule?
5-Amino-1MQ is a small-molecule quinolinium derivative (C10H11N2+), not a peptide composed of amino acid chains. Its small structure allows rapid cellular membrane permeability.
What solvent is recommended for reconstituting 5-Amino-1MQ in the lab?
5-Amino-1MQ exhibits high solubility in dimethyl sulfoxide (DMSO) and moderate solubility in aqueous buffers such as phosphate-buffered saline (PBS) depending on the salt formulation.
How are endotoxin levels verified in 5-Amino-1MQ batches?
Endotoxin levels are measured using a quantitative Limulus Amebocyte Lysate (LAL) assay, ensuring the compound meets strict preclinical limits to prevent inflammatory or pyrogenic artifacts in cell culture.
What are the optimal storage conditions for 5-Amino-1MQ powder?
Solid powder should be stored desiccated at -20°C or -80°C away from light. Reconstituted DMSO stock aliquots should be frozen at -80°C to avoid repeated freeze-thaw cycles.
Where is PX1 Research 5-Amino-1MQ manufactured and tested?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and tested by third-party ISO 17025 accredited analytical laboratories per individual production lot.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.